Skip to main content
Log in

Astragalus membranaceus Injection combined with conventional treatment for viral myocarditis: A systematic review of randomized controlled trials

  • Evidence-Based Integrative Medicine
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To assess the efficacy and safety of Astragalus membranaceus Injection combined with conventional therapy in the treatment of viral myocarditis.

Methods

Randomized controlled trials (RCTs) of A. membranaceus Injection combined with conventional treatment compared with conventional treatment alone were included. Study population characteristics and outcome results were extracted independently by two assessors. Meta-analysis was performed for data available.

Results

Six RCTs, involving 639 participants, were included in this study. The methodological quality of the included trials was generally low, and there was high risk of publication bias in the included trials. The total effective rate of A. membranaceus Injection combined with conventional treatment was significantly higher than that of conventional treatment alone. Compared with conventional treatment, the cointervention treatment group showed significant recovery in myocardium enzyme levels and electrocardiography. Two RCTs reported there were no adverse effects from A. membranaceus Injection combined with conventional treatment.

Conclusion

A. membranaceus Injection combined with conventional treatment appeared to be more efficacious compared with conventional treatment alone for treating viral myocarditis. However, this conclusion should be cautiously interpreted due to low methodological quality, small sample size, limited number of trials, and high risk of publication bias and other unidentified risks of bias. The safety of A. membranaceus Injection combined with conventional treatment remains uncertain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sagar S, Liu PP, Cooper Jr LT. Myocarditis. Lancet 2012;379:738–747.

    Article  PubMed  Google Scholar 

  2. Cooper Jr LT. Myocarditis. N Engl J Med 2009;360:1526–1538.

    Article  PubMed  CAS  Google Scholar 

  3. Schulthz JC, Hilliard AA, Cooper Jr LT, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 2009;84:1001–1009.

    Article  Google Scholar 

  4. Liu ZL, Liu ZJ, Liu JP, Kwong JS. Herbal medicines for viral myocarditis. Cochrane Database Syst Rev 2012;11:CD003711.

    PubMed  Google Scholar 

  5. Chen XJ, Bian ZP, Lu S, Xu JD, Gu CR, Yang D, et al. Cardiac protective effect of Astragalus on viral myocarditis mice: comparison with Perindopril. Am J Chin Med 2006;34:493–502.

    Article  PubMed  CAS  Google Scholar 

  6. Guan FY, Liu Y, Li H, Yang SJ. Protective effects of Astragalus membranaceus Injection on viral myocarditis in mice. J Jilin Univ Med Edition (Chin) 2005;31:717–719.

    Google Scholar 

  7. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials 1996;17:1–12.

    Article  PubMed  CAS  Google Scholar 

  8. Zou FW. Astragalus Injection treatment on 48 patients with viral myocarditis. China Pharmaceuticals (Chin) 2001;10:38.

    Google Scholar 

  9. Guo YC. Effects of Astragalus membranaceus Injection on children’s viral myocarditis. Lishizhen Med Mater Med Res (Chin) 2003;14:408.

    Google Scholar 

  10. Zhang YF, Yang GD, Mao LX. Clinical observation on therapeutic effects of integrated traditional Chinese and Western medicine in treatment of acute viral myocarditis. Chin J Integr Tradit West Med Inten Crit Care (Chin) 2005;12:363–365.

    Google Scholar 

  11. Wu YX. Astragalus membranaceus Injection treatment on 119 children with viral myocarditis. China Pract Med (Chin) 2009;4:161.

    Google Scholar 

  12. Wang LJ. Effects of Astragalus membranaceus Injection on viral myocarditis in children. China Modern Med (Chin) 2011;18:55–56.

    Google Scholar 

  13. Wang YQ, Jiang AL. Clinical observation of Astragalus membranaceus Injection on viral myocarditis in children. Guide China Med (Chin) 2012;10:267–278.

    Google Scholar 

  14. Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: metaepidemiological study. BMJ 2013;346:f2304.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gu YH, Du JX. Adverse drug reactions induced by Astragalus membranaceus Injection: analysis of 95 cases. China Pharm (Chin) 2012;23:334–336.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiao-chun Liang  (梁晓春).

Additional information

Supported by the Health Industry Scientific Research Special Funding Subproject (No. 200902008-04)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piao, Yl., Liang, Xc. Astragalus membranaceus Injection combined with conventional treatment for viral myocarditis: A systematic review of randomized controlled trials. Chin. J. Integr. Med. 20, 787–791 (2014). https://doi.org/10.1007/s11655-014-1825-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-014-1825-3

Keywords

Navigation